Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

Change Font Size

Prescription Opioid Drug Abuse and Misuse Prevention - Prescription Drug Monitoring Programs

Opioid abuse and related overdoses are a national epidemic. According to the Centers for Disease Control and Prevention (CDC), more than 33,000 people died in 2015 from overdoses involving opioids, both prescription and illicit, an increase from approximately 28,000 deaths in 2014. HHS, through CDC and the Substance Abuse and Mental Health Services Administration (SAMHSA), provides funding to States to prevent opioid abuse and misuse. Funding is provided by CDC's Prescription Drug Overdose: Prevention for States program and SAMHSA's Strategic Prevention Framework for Prescription Drugs program. Our objectives are to identify actions State agencies have taken using Federal funds for enhancing prescription drug monitoring programs (PDMPs) to achieve program goals -- improving safe prescribing practices and preventing prescription drug abuse and misuse. We will also determine whether State agencies complied with Federal requirements. This series of audits includes States that have had a high number of overdose deaths, have a significant increase in the rate of drug overdose deaths, or received HHS funding to enhance their PDMPs.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
December 2017 Substance Abuse and Mental Health Services Administration Prescription Opioid Drug Abuse and Misuse Prevention - Prescription Drug Monitoring Programs Office of Audit Services W-00-18-59428

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201